Science AI Journal
Try Pre-Check Free

Recent papers on drug tablet classes formulations evaluation

Sorted by publication year (newest first) via OpenAlex. List regenerates every 24h.

  1. SOLUBILITY ENHANCEMENT, FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED-RELEASE TABLETS OF BCS CLASS IV DRUGS TICAGRELOR

    2026 · International Journal of Applied Pharmaceutics · INAMDAR, MAHESH, Shendge, Rajan S.

    2026

  2. Formulation And Evaluation Of Immediate Release Tablet Of A B.C.S Class Iii Anti-Depressant Drug

    2024 · African Journal of Biomedical Research · Tyagi, Sahil

    2024

  3. FORMULATION AND IN-VITRO EVALUATION OF TASTE MASKED ORALLY DISINTEGRATING TABLETS OF A BITTER BCS CLASS II DRUG

    2021 · Zenodo (CERN European Organization for Nuclear Research) · Triveni, Madhu Gudipati Yarlagadda

    2021

  4. Formulations 2019: Statistical Optimization and In-Vitro Evaluation of Beta Cyclodextrin Complexed Oral Matrix Tablet of Class-II Drug Glipizide for the treatment of Diabetes mellitus - Rajesh Jagtap - Annasaheb Dange College of B. Pharmacy

    2019 · Journal of Drug Delivery and Therapeutics · Jagtap, Rajesh

    2019

  5. Optimized Formulation of Carvedilol Fast-Dissolving Tablets Using Modified Super disintegrants: Breaking Solubility Barriers of BCS Class II Drugs

    2026 · Indian Journal of Pharmaceutical Education and Research · Vadaga, Anilkumar, Rada, Santosh Kumar

    2026

  6. First-in-class drug oroxylin A tablets for treating hepatic and gastrointestinal disorders: from preclinical development to clinical research

    2025 · Chinese Journal of Natural Medicines · Luo, Chengju, Li, Xuhong, Gao, Yuan et al.

    2025

  7. Application of Physiologically Based Biopharmaceutics Modeling (PBBM) to Establish Clinically Relevant Dissolution Specifications for a Prolonged Release Tablet Formulation of Verapamil, a BCS Class I Drug

    2025 · AAPS PharmSciTech · Damre, Anagha, Banerjee, Aniruddha

    2025

  8. Development and Characterization of Fast-dissolving Tablets to Enhance Bioavailability of BCS Class II Drugs by Solid Dispersion Method

    2024 · Current Pharmaceutical Analysis · Sathish, Samathana Kanagaraj, Janakiraman, Kunchithapadam, Muthumani, M.Latha

    2024

  9. Evaluation of Pharmacokinetics of a BCS Class III Drug with Two Different Study Designs: Tenofovir Alafenamide Monofumarate Film-coated Tablet

    2024 · AAPS PharmSciTech · Arısoy, Mustafa, Saydam, Mehtap, Dolaksız, Yasemin Ekin et al.

    2024

  10. The results of I phase clinical study of class III antiarrhythmic drug, tablet form

    2024 · Siberian Journal of Clinical and Experimental Medicine · Yuricheva, Yu. A., Дзаурова, Х. М., Beliaeva, Maria M. et al.

    2024

  11. GC-FID-HS method development and validation for quantitative estimation of ethanol as residual in tablets drug product from the class of benzodiazepine

    2023 · Macedonian Pharmaceutical Bulletin · Blažeska, Olivera, Anevska-Sojanovska, Natasa, Lazova, Jelena

    2023

  12. Design and Evaluation of Fast Dissolving Tablets a Novel Natural Superdisintegrant is used in the Development of a BCS Class -II Drug

    2023 · Research Journal of Pharmacy and Technology · Naik, D. Chandra Sekhar, Bharathi, A.

    2023

  13. Development of Robust Tablet Formulations with Enhanced Drug Dissolution Profiles from Centrifugally-Spun Micro-Fibrous Solid Dispersions of Itraconazole, a BCS Class II Drug

    2023 · Pharmaceutics · Marano, Stefania, Ghimire, Manish, Missaghi, Shahrzad et al.

    2023

  14. Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug

    2023 · Drug Design Development and Therapy · Bashir, Muhammad Anwar, Khan, Amjad, Shah, Sayyed Ibrahim et al.

    2023

  15. Drug-Polymers Composite Matrix Tablets: Effect of Hydroxypropyl Methylcellulose (HPMC) K-Series on Porosity, Compatibility, and Release Behavior of the Tablet Containing a BCS Class I Drug

    2022 · Polymers · Hirun, Namon, Kraisit, Pakorn

    2022

  16. Clinical study of tablet form of domestic antiarrhythmic drug class III on healthy volunteers

    2022 · Russian Cardiology Bulletin · Yuricheva, Y.A., Mironov, N. Yu., Dzaurova, K.M. et al.

    2022

  17. In-vitro evaluation of the beta cyclodextrin complexed oral matrix tablet of class-II drug glipizide for the treatment of diabetes mellitus

    2021 · Journal of Drug Delivery and Therapeutics · Rajesh

    2021

  18. Comparison of Release Retardant Effect of Some Novel Lipids by Formulating Sustained Release Tablet of BCS Class 1 Drug

    2020 · Indian Journal of Pharmaceutical Education and Research · Devi, R. Aruna, Sharma, Ram Babu, Sharma, Abhishek et al.

    2020

  19. Development and Validation of <i>In Vitro</i> Discriminatory Dissolution Testing Method for Fast Dispersible Tablets of BCS Class II Drug

    2020 · Turkish Journal of Pharmaceutical Sciences · Bhatt, Shailendra, ROY, Dabashis, Kumar, Manish et al.

    2020

  20. Pharmacological action and clinical effect of tedizolid phosphate (SIVEXTRO<sup>®</sup> Tablets 200 mg, for iv infusion 200 mg), a novel oxazolidinone-class antibacterial drug

    2020 · Folia Pharmacologica Japonica · Mori, Masahiko, Takase, Akiko

    2020

  21. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs

    2019 · European Journal of Pharmaceutics and Biopharmaceutics · Zaheer, Kamran, Langguth, Peter

    2019

  22. Effect of Filler Hydrophilicity on Superdisintegrant Performance and Release Kinetics From Solid Dispersion Tablets of A Model BCS Class II Drug

    2019 · International journal of pharmacy research and technology · Mitra, Indranil, Majee, Gopa Roy Biswas And Sutapa Biswas

    2019

  23. Studies on Release Performance of Proniosmes and its Tablets of BCS Class II Drug Simvastatin

    2018 · Der pharmacia lettre · Shete, Amol, Sathe, Mahendra, Doijad, Rajendra

    2018

  24. Biocompatible interpolymer complex matrix tablets - an oral sustained release class-III antidiabetic drug

    2017 · IOP Conference Series Materials Science and Engineering · Haque, Sk Ershadul, Sheela, Angappan

    2017

  25. Modified geometry three-layered tablet as a platform for class II drugs zero-order release system

    2017 · Tropical Journal of Pharmaceutical Research · Albogami, Abdullah, Omer, Mustafa E., Bekairy, Abdulkareem M. Al et al.

    2017

  26. Formulation and Optimization of Solid Self Micro Emulsifying Tablet of Bcs Class ii Drugs

    2016 · Shodhganga · Swayamprakash, Patel

    2016

  27. DRUG DEVELOPMENT BY MOLECULAR HYBRIDIZATION: A MEDICINAL CHEMISTRY PRACTICE CLASS USING PARACETAMOL AND SULFADIAZINE TABLETS AND THE VIRTUAL TOOL<i>SciFinder</i><sup>®</sup>

    2015 · Química Nova · Araújo, Cleônia Roberta Melo, Filho, Carlos Alberto Leite, Santos, Victória Laysna dos Anjos et al.

    2015

  28. Determining the Polymer Threshold Amount for Achieving Robust Drug Release from HPMC and HPC Matrix Tablets Containing a High-Dose BCS Class I Model Drug: In Vitro and In Vivo Studies

    2014 · AAPS PharmSciTech · Klančar, Uroš, Baumgartner, Saša, Legen, Igor et al.

    2014

  29. Assessment of Formulation Factors on the Release Behaviour of BCS Class II Drug from Tablet Dosage form Using DoE

    2014 · Current Drug Delivery · Syamala, Urmila, Kumar, Raman, Pushkarajan, Tambi et al.

    2014

Command palette

Jump anywhere, run any action.